Neoadjuvant chemotherapy versus upfront debulking surgery in advanced tubo-ovarian cancer

Research output: Contribution to journalComment/debate

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)1558-1560
Number of pages3
JournalThe Lancet Oncology
Volume19
Issue number12
DOIs
Publication statusPublished - Dec 1 2018

ASJC Scopus subject areas

  • Oncology

Cite this

Neoadjuvant chemotherapy versus upfront debulking surgery in advanced tubo-ovarian cancer. / Fagotti, Anna; Scambia, Giovanni.

In: The Lancet Oncology, Vol. 19, No. 12, 01.12.2018, p. 1558-1560.

Research output: Contribution to journalComment/debate

@article{5c3da884a73c4b749176d3fe16c7198f,
title = "Neoadjuvant chemotherapy versus upfront debulking surgery in advanced tubo-ovarian cancer",
author = "Anna Fagotti and Giovanni Scambia",
year = "2018",
month = "12",
day = "1",
doi = "10.1016/S1470-2045(18)30625-9",
language = "English",
volume = "19",
pages = "1558--1560",
journal = "The Lancet Oncology",
issn = "1470-2045",
publisher = "Lancet Publishing Group",
number = "12",

}

TY - JOUR

T1 - Neoadjuvant chemotherapy versus upfront debulking surgery in advanced tubo-ovarian cancer

AU - Fagotti, Anna

AU - Scambia, Giovanni

PY - 2018/12/1

Y1 - 2018/12/1

UR - http://www.scopus.com/inward/record.url?scp=85059336443&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059336443&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(18)30625-9

DO - 10.1016/S1470-2045(18)30625-9

M3 - Comment/debate

AN - SCOPUS:85059336443

VL - 19

SP - 1558

EP - 1560

JO - The Lancet Oncology

JF - The Lancet Oncology

SN - 1470-2045

IS - 12

ER -